Karen Akinsanya
Director/Board Member bij NAUTILUS BIOTECHNOLOGY, INC.
Vermogen: - $ op 31-03-2024
Profiel
Karen Akinsanya is the founder of Envision Science Group LLC, which was founded in 2007.
She holds the title of President at Envision Science Group LLC.
Dr. Akinsanya's current jobs include being an Independent Director at Nautilus Biotechnology, Inc. since 2022, a Trustee at The Rockefeller University, and the President-Research & Development Therapeutics at Schrödinger, Inc. since 2018.
Dr. Akinsanya's former job was as a Vice President at Merck & Co., Inc. from 2013 to 2017.
She received her undergraduate degree from Queen Mary University of London and her doctorate from Royal Postgraduate Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SCHRODINGER, INC.
-.--% | 04-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Karen Akinsanya
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHRÖDINGER, INC. | Corporate Officer/Principal | 01-04-2018 |
| NAUTILUS BIOTECHNOLOGY, INC. | Director/Board Member | 30-03-2022 |
| Envision Science Group LLC | Founder | 01-01-2007 |
| The Rockefeller University | Director/Board Member | - |
Eerdere bekende functies van Karen Akinsanya
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01-07-2017 |
Opleiding van Karen Akinsanya
| Queen Mary University of London | Undergraduate Degree |
| Royal Postgraduate Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Envision Science Group LLC |
